Responsibilities
- Perform routine manufacturing tasks, including media preparation, cell culture, cell counting, formulation, centrifugation, and freezing.
- Complete and ensure timely, accurate documentation in compliance with GMP standards across batch records, forms, and protocols.
- Mentor fellow team members on cGMP documentation protocols to ensure the highest standards.
- Plan, collect, analyze, and report on production data, maintaining comprehensive records and observations.
- Author, revise, and maintain SOPs through Capricor’s document change system.
- Oversee inventory, material transfers, and cleanroom procedures to support efficient GMP operations.
- Prepare technical summaries, protocols, and reports to ensure full documentation of production activities.
- Lead moderate-complexity CAPAs and assist with deviations and investigations to maintain quality assurance.
- Take on special projects in manufacturing and development as required.
Requirements
- Bachelor’s degree in Biomedical Engineering, Biological Sciences, or a related field.
- 1-3 years of experience in a cGMP/cGTP manufacturing environment.
- Solid laboratory experience in mammalian tissue culture, along with expertise in aseptic techniques.
- Working knowledge of regulatory standards in biopharmaceutical or tissue banking industries.
- Strong organizational skills and acute attention to detail within a fast-paced, dynamic setting.
- Basic molecular biology and flow cytometry skills are a plus.
- Adaptability to work schedules that may include weekends or holidays as needed.
Why Capricor?
Capricor Therapeutics is advancing cell and exosome-based therapies with a focus on serious diseases where patients and families need new treatment options. Our work is grounded in scientific rigor, collaboration, and a shared commitment to moving meaningful therapies forward. Joining Capricor means being part of a mission-driven team working at the intersection of innovation, execution, and patient impact.
Come Work With Us
At Capricor, you’ll join a collaborative environment where employees are encouraged to contribute, grow, and help build the systems, science, and operations needed to support our next stage of growth. We value people who are thoughtful, accountable, hands-on, and motivated by work that can make a real difference.
Recruiting Fraud Notice
Capricor does not use Skype for interviews or recruiting activities. Candidates will only be contacted by someone using an official Capricor email address ending in @capricor.com. Capricor will never ask candidates to send money, deposit a check, purchase equipment, or provide payment for any reason as part of the recruiting or onboarding process.
Notice to Recruiting Agencies
Capricor Therapeutics does not accept candidate submissions or referrals from recruiting agencies, staffing firms, or third-party recruiters without express written approval from Talent Acquisition and a fully executed agreement with Capricor. Agencies that contact hiring managers directly, solicit business, or submit candidates without prior approval will not be considered for engagement. Any unsolicited submissions will become the property of Capricor Therapeutics, and no fees will be paid for candidates hired as a result of such submissions. We appreciate your cooperation and respect for this policy.
Skills Required
- Bachelor's degree in Biomedical Engineering, Biological Sciences, or related field.
- 1-3 years of experience in a cGMP/cGTP manufacturing environment.
- Solid laboratory experience in mammalian tissue culture and aseptic technique.
- Experience with media preparation, cell counting, formulation, centrifugation, and freezing.
- Working knowledge of regulatory standards in biopharmaceutical or tissue banking industries.
- Strong organizational skills and attention to detail in a fast-paced environment.
- Adaptability to work schedules that may include weekends or holidays.
- Basic molecular biology and flow cytometry skills.
What We Do
Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of cell and exosome-based therapeutics. Its lead product candidate, Deramiocel, is an allogeneic cell therapy currently in late-stage clinical development for the treatment of Duchenne muscular dystrophy (DMD). The company also leverages its proprietary StealthX™ exosome platform for the targeted delivery of therapeutic agents to treat a wide range of diseases.









